MBRX
Moleculin BiotechFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
MBRX vs peer average
30/100
MBRX vs. peer average (F vs. D)
Grade spread
B 1 · C 2 · D 3 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
SNGX is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $7.62M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MBRX
Moleculin Biotech
SNGX
Soligenix
Grade
F
C
Momentum
67
18
Value
41
58
Sentiment
0
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs SNGX
MBRX / SNGX
Grade Position
Below peers
MBRX vs. peer average (F vs. D)
30/100
Momentum
67
MBRXValue
41
SNGXSentiment
0
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MBRX
SNGX is the first peer returned for this comparison set.